Search

Displaying results 8821 - 8830 of 10000 in total
  1. Drug

    Dinaciclib

    go.drugbank.com/drugs/DB12021
    Investigational

    Dinaciclib has been used in trials studying the treatment of rrMM, rrCLL, rrDLBCL, Solid Tumors, and Solid Neoplasm, among others.

  2. Drug

    Ganetespib

    go.drugbank.com/drugs/DB12047
    Investigational

    Ganetespib is under investigation for the treatment of BREAST CANCER, Small Cell Lung Cancer, Acute Myeloid Leukaemia, and Myelodysplastic Syndrome.

  3. Drug

    UK-396,082

    go.drugbank.com/drugs/DB12099
    Investigational

    UK-396,082 has been used in trials studying the basic science of Safety, Phase 1, Toleration, Multiple Dose, and Pharmacokinetic.

  4. Drug

    Rezatomidine

    go.drugbank.com/drugs/DB12143
    Investigational

    Rezatomidine has been used in trials studying the treatment of Fibromyalgia, Cystitis, Interstitial, Irritable Bowel Syndrome, and Diabetic Neuropathy, Painful.

  5. Drug

    Eplivanserin

    go.drugbank.com/drugs/DB12177
    Investigational

    Eplivanserin has been used in trials studying the treatment of Sleep, Insomnia, Chronic Pain, Fibromyalgia, and Primary Insomnia, among others.

    Categories: Serotonin Receptor Antagonists
  6. Drug

    Tetulomab tetraxetan Lu-177

    go.drugbank.com/drugs/DB12227
    Investigational

    Betalutin has been used in trials studying the treatment of Non-Hodgkin Lymphoma and Relapsed, Diffuse Large B-cell Lymphoma.

  7. Drug

    Fexagratinib

    go.drugbank.com/drugs/DB12247
    Investigational

    AZD4547 has been used in trials studying the treatment of Cancer, LYMPHOMA, Gastric Cancer, Adenocarcinoma, and Solid Neoplasm, among others.

  8. Drug

    SGI-1776

    go.drugbank.com/drugs/DB12494
    Investigational

    SGI-1776 has been used in trials studying the treatment of Prostate Cancer, Non-Hodgkins Lymphoma, and Relapsed/Refractory Leukemias.

  9. Drug

    DLO6002

    go.drugbank.com/drugs/DB05179
    Experimental

    DLO6002 is developed by Summit Corporation and is in phase I of clinical trials for the treatment of Parkinson's disease.

  10. Drug

    WNT-974

    go.drugbank.com/drugs/DB12561
    Investigational

    WNT974 has been used in trials studying the treatment of Metastatic Colorectal Cancer and Squamous Cell Carcinoma, Head And Neck.